✦ LIBER ✦

Preliminary results of a dose-intense phase II study of a combination chemotherapy regimen with Cisplatin (CDDP) and Epirubicin (EPI) including Medroxyprogesterone Acetate (MPA) and recombinant interleukin 2 (rIL-2) in patients with inoperable primary lung cancer

✍ Scribed by Mantovani, G.; Macciò, A.; Lai, P.; Massa, E.; Mudu, M.C.; Manca, G.; Mulas, C.; Massa, D.; Succu, G.; Versace, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preliminary results of a dose-intense ph

✍ G. Mantovani; A. Macciò; P. Lai; E. Massa; M.C. Mudu; G. Manca; C. Mulas; D. Mas 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Results of a dose-intense phase II study

✍ Mantovani, G; Macciò, A; Massa, E; Mudu, M.C; Manca, G; Mulas, C; Massa, D; Succ 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB